TrialAdvances in therapy2025

Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study.

Jonathan A Bernstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.